Find stats on top websites
Major Markets
Canada
United States
United KingdomKey Competitors
VBI Vaccines Top Products
Brand Positioning
VBI Vaccines positioned itself as an immunology-driven biotech company leveraging innovative VLP technology for vaccine and immunotherapeutic development, focused on preventing and treating infectious diseases and oncology.
Customer Sentiments
Customer sentiment is likely negative due to the recent recall of PreHevbrio and the company's operational discontinuation, indicating a significant breach of trust and reliability for institutional purchasers. The restructuring under CCAA suggests severe operational distress, further eroding confidence among stakeholders.
VBI Vaccines Key Value Propositions
VBI Vaccines' core value proposition was 'Activating the Power Within' by leveraging innovative immunology and virus-like particle (VLP) technology to develop potent prophylactic vaccines and immunotherapeutics. Their aim was to elicit robust immune responses for both preventing and treating diseases, addressing unmet medical needs in infectious diseases and oncology.
VBI Vaccines SWOT Analysis
Strengths
Strong executive leadership with big pharma experience.
Focus on innovative immunology and VLP technology.
Track record of commercializing a vaccine (PreHevbrio).
Weaknesses
Operational discontinuation and product recall.
Significant restructuring phase (CCAA proceedings).
Uncertain future and potential liquidation.
Opportunities
Address unmet public health and medical needs.
Strategic partnerships for pipeline development.
Leverage expertise for new ventures post-restructuring.
Threats
Intense competition from major pharmaceutical companies.
High regulatory hurdles and clinical trial risks.
Funding challenges during restructuring and post-recall stigma.
Market Growth Stage
Pace of Market Growth
VBI Vaccines Target Audience
Geographic Insights
Historically strong presence in Canada with significant U.S. commercial ties, reflecting global healthcare market focus for vaccine distribution.
Top Countries
Canada
40% market share
United States
35% market share
United Kingdom
5% market share
Germany
4% market share
France
3% market share
VBI Vaccines Audience Segments
Institutional Procurement Specialists
30-65 years
Male • Female
North America • Europe • Asia
Biopharma R&D Leaders
35-60 years
Male • Female
Global
Public Health Policy Makers
40-70 years
Male • Female
Global
Biotech Investors & Strategists
28-55 years
Male • Female
North America • Europe
Healthcare Supply Chain Managers
35-60 years
Male • Female
Global
Social Media Usage Across Segments
Data shown in percentage (%) of usage across platforms
Recommended Marketing Strategiesfor VBI Vaccines
Leverage User-Generated Content (UGC)
Showcasing user-generated content builds trust and provides social proof, especially valuable considering the company's past challenges. Featuring authentic testimonials, images, or videos from past users (if available) can help rebuild credibility and demonstrate the product's effectiveness.
Learn moreProduct Satisfaction Guarantee
Offering a product satisfaction guarantee can alleviate customer concerns, especially after the recall. This reduces the perceived risk associated with trying their products, encouraging initial adoption and rebuilding consumer confidence.
Learn morePersonalized User Onboarding
Tailoring the onboarding experience for different customer segments (e.g., healthcare providers, researchers) can enhance engagement and product understanding. This ensures that users quickly grasp the value of the product or new offerings, increasing the likelihood of adoption and long-term satisfaction.
Learn moreTransform Your Ideas into Action in Minutes with WaxWing
Sign up now and unleash the power of AI for your business growth
